Market closed
Rafael Holdings/$RFL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Rafael Holdings
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
Ticker
$RFL
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
30
ISIN
US75062E1064
Website
Rafael Holdings Metrics
BasicAdvanced
$36M
-
-$2.11
1.15
-
Price and volume
Market cap
$36M
Beta
1.15
52-week high
$2.12
52-week low
$1.32
Average daily volume
126K
Financial strength
Current ratio
9.259
Quick ratio
6.824
Long term debt to equity
0.103
Total debt to equity
3.292
Interest coverage (TTM)
-126.38%
Management effectiveness
Return on assets (TTM)
-47.85%
Return on equity (TTM)
-93.45%
Valuation
Price to revenue (TTM)
48.582
Price to book
0.51
Price to tangible book (TTM)
0.53
Price to free cash flow (TTM)
-4.108
Growth
Revenue change (TTM)
156.73%
Earnings per share change (TTM)
-2,366.88%
3-year revenue growth (CAGR)
-9.26%
3-year earnings per share growth (CAGR)
-33.29%
Rafael Holdings News
AllArticlesVideos
Rafael Holdings, Inc. Announces Proposed Terms of a $25 Million Rights Offering to Support Its Commitment to the Development and Potential Launch of Trappsol® Cyclo™
GlobeNewsWire·3 weeks ago
Rafael Holdings Strengthens its Focus on the Development of Trappsol® Cyclo™ and Announces Chief Executive Officer Bill Conkling Will Be Stepping Down from His Role
GlobeNewsWire·3 weeks ago
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Rafael Holdings stock?
Rafael Holdings (RFL) has a market cap of $36M as of May 17, 2025.
What is the P/E ratio for Rafael Holdings stock?
The price to earnings (P/E) ratio for Rafael Holdings (RFL) stock is 0 as of May 17, 2025.
Does Rafael Holdings stock pay dividends?
No, Rafael Holdings (RFL) stock does not pay dividends to its shareholders as of May 17, 2025.
When is the next Rafael Holdings dividend payment date?
Rafael Holdings (RFL) stock does not pay dividends to its shareholders.
What is the beta indicator for Rafael Holdings?
Rafael Holdings (RFL) has a beta rating of 1.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.